Related Experiment Video
Updated: Apr 23, 2026

Author Spotlight: A Comprehensive Protocol for Acinetobacter Biofilm Quantification, Assessment, and Visualization
Published on: August 4, 2023
Update on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections
Uh Jin Kim1, Hee Kyung Kim1, Joon Hwan An1
1Department of Infectious Diseases, Chonnam National University Medical School, Gwangju, Korea.
Abstract:
Carbapenem-resistant Acinetobacter species are increasingly recognized as major nosocomial pathogens, especially in patients with critical illnesses or in intensive care. The ability of these organisms to accumulate diverse mechanisms of resistance limits the available therapeutic agents, makes the infection difficult to treat, and is associated with a greater risk of death. In this review, we provide an update on the epidemiology, resistance mechanisms, infection control measures, treatment, and outcomes of carbapenem-resistant Acinetobacter infections.
Insights
Carbapenem-resistant Acinetobacter infections are a growing threat in hospitals, particularly for critically ill patients. This review details their spread, resistance, and treatment challenges.
Area of Science:
- Infectious Diseases
- Microbiology
- Critical Care Medicine
Background:
- Carbapenem-resistant Acinetobacter species are significant nosocomial pathogens.
- These infections are prevalent in intensive care units and critically ill patients.
- Acquired resistance mechanisms complicate treatment and increase mortality.
Purpose of the Study:
- To provide an updated review on carbapenem-resistant Acinetobacter infections.
- To cover epidemiology, resistance mechanisms, and infection control.
- To discuss treatment strategies and patient outcomes.
Main Methods:
- Literature review of recent studies on carbapenem-resistant Acinetobacter.
- Synthesis of data on epidemiology and resistance patterns.
- Analysis of current treatment guidelines and outcomes.
Main Results:
- Increasing prevalence of carbapenem-resistant Acinetobacter globally.
- Diverse and complex resistance mechanisms identified.
- Limited effective therapeutic options and high mortality rates.
Conclusions:
- Carbapenem-resistant Acinetobacter poses a major challenge in healthcare settings.
- Effective infection control and novel treatment strategies are crucial.
- Further research is needed to combat these resistant pathogens.
More Related Videos
05:06Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
08:37The Application of Open Searching-based Approaches for the Identification of Acinetobacter baumannii O-linked Glycopeptides
Published on: November 2, 2021
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...